Jasper Therapeutics, Inc.

NASDAQ:JSPR

5.55 (USD) • At close June 30, 2025
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Omzet 000002.052000000000000000
Kosten van de omzet 00.24500.2990.2880.2830.2760.3770.3730.3670.3580.3130.2720.230.336000000
Brutowinst 00.5870-0.299-0.288-0.283-0.276-0.377-0.373-0.367-0.358-0.313-0.272-0.23-0.336000000
Brutowinstmarge 00000-0.138000000000000000
Onderzoek- en ontwikkelingskosten 16.15719.77214.45511.29610.29813.83514.84813.2979.8059.2829.0228.1358.1888.6577.1885.1564.424.6474.524.7761.94
Algemene en administratieve kosten 5.6455.5135.4344.6974.7743.894.5144.534.1424.4653.6863.8284.593.4252.8913.2621.8341.3111.4881.2360.765
Verkoop- en marketingkosten 00.28800-0.288-0.283000000000000000
Verkoop-, algemene en administratieve kosten 5.6455.8015.4344.6974.4863.6074.5144.534.1424.4653.6863.8284.593.4252.8910.5621.8341.3111.4881.2360.765
Overige kosten 00.0620-0.04-0.022-0.1180.051-0.109-0.070.30100.089-0.072000.0040.0010000
Bedrijfskosten 21.80225.0419.88915.99314.78417.44219.36217.82713.94713.74712.70811.96312.77812.08210.0798.4186.2545.9586.0086.0121.483
Bedrijfsresultaat -21.802-25.285-19.889-15.993-15.072-17.725-19.362-17.827-13.947-13.747-12.708-11.963-12.778-12.082-10.079-8.418-6.254-5.958-6.008-6.012-2.705
Bedrijfsresultaat ratio 00000-8.638000000000000000
Totaal overige inkomsten en kosten netto 0.5610.9641.2521.411.3441.1441.8181.747-0.3130.5360.8451.55910.5713.0256.6670.004-3.5-4.029-4.817-3.4111.271
Inkomen voor belasting -21.241-24.321-18.637-14.583-13.728-16.581-17.544-16.08-14.26-13.211-11.863-10.404-2.207-9.057-3.412-8.414-9.754-9.987-10.825-9.4230.097
Inkomen voor belasting ratio 00000-8.08000000000000000
Belastingkosten 00.0540-0.2990.2451.913-1.709-1.8561.652-0.536-1.113-1.559-10.571-9.301-0.132-0.0047.0014.0294.7060.0011.271
Nettowinst -21.241-24.321-18.637-14.583-13.728-16.581-17.544-16.08-14.26-13.211-11.863-10.404-2.207-9.057-3.412-8.414-9.754-9.987-10.825-9.423-1.434
Nettowinstmarge 00000-8.08000000000000000
WPA (Winst Per Aandeel) -1.413.22-1.24-0.97-1.03-1.5-1.6-1.47-1.62-3.6-3.2-2.9-0.6-1.82-6.9-0.22-0.26-0.26-0.29-16.080
Verwaterde WPA -1.413.22-1.24-0.97-1.03-1.5-1.6-1.47-1.8-3.6-3.2-2.9-0.6-1.82-6.9-0.22-0.26-0.26-0.29-16.060
EBITDA -21.52345.874-19.348-15.694-14.784-17.442-19.086-17.552-13.673-13.474-12.44-11.745-12.562-15.063-3.271-8.389-6.232-0.088-6.00802.573
EBITDA ratio 00000-8.5000000000000000